Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of Psychosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01619319|
Recruitment Status : Completed
First Posted : June 14, 2012
Last Update Posted : September 5, 2014
|Condition or disease||Intervention/treatment||Phase|
|Prodromal Schizophrenia||Other: Cognitive Remediation Therapy Other: computer games||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||32 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of Psychosis|
|Study Start Date :||July 2010|
|Actual Primary Completion Date :||August 2014|
|Actual Study Completion Date :||August 2014|
Experimental: Cognitive Remediation Therapy
A computerised cognitive remediation intervention called the Brain Fitness program is compared against a placebo intervention consisting of computer games
Other: Cognitive Remediation Therapy
auditory computer games designed to improve the speed at which people react when they hear something and at which they process that information.
Other Name: Brain Fitness Program
Active Comparator: computer games
Other: computer games
computer games that that consist of word puzzles
Other Name: Hoyle Puzzle and Board Games
- Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) [ Time Frame: 12 months ]MATRICS will be used to assess changes in cognition at the end of treatment and 12 months post baseline.
- GFS= Global Functioning Scale (GFS): Social and Role [ Time Frame: 12 months ]Functioning scales will be used to asses if changes in cognitive function are associated with changes in social and role functioning.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01619319
|Principal Investigator:||Jean Addington, PhD||University of Calgary|